Transjugular Approach for Evoque Transcatheter Tricuspid Valve Replacement in Patients With Challenging Anatomy.
Document Type
Article
Publication Date
8-19-2025
Publication Title
Circulation. Cardiovascular interventions
Abstract
BACKGROUND: The Evoque system is the first commercially available transcatheter tricuspid valve replacement (TTVR) system in the United States. However, challenging anatomy in real-world patients could preclude successful transfemoral Evoque TTVR. We aim to investigate the feasibility of the transjugular Evoque TTVR in anatomy unsuitable for a transfemoral approach.
METHODS: Eleven patients with challenging anatomy underwent transjugular Evoque TTVR at a high-volume center in the United States from February 2024 to January 2025, following an unsuccessful transfemoral attempt (n=9) or anatomic unsuitability (n=2). Procedural characteristics, intraprocedural success, periprocedural outcomes, echocardiographic findings, and 30-day clinical outcomes were assessed using the Tricuspid Valve Academic Research Consortium definitions. The procedural technique is provided in the accompanying supplement.
RESULTS: Intraprocedural success was achieved in all 11 patients, with reasonable procedural time and no major procedural complications, except for 1 pacemaker implantation. At 30 days, the clinical success rate was 100%. Tricuspid regurgitation was reduced to none-to-trivial in 8 patients, mild in 2 patients, and moderate in 1 patient. There was no stroke, mortality, or rehospitalization. Nine out of 11 patients experienced an improvement in New York Heart Association functional class.
CONCLUSIONS: In the largest single-center cohort of patients reported to date, transjugular Evoque TTVR demonstrated favorable intraprocedural, periprocedural, and short-term clinical outcomes, and was found to be a feasible alternative for patients with anatomy unsuitable for transfemoral Evoque TTVR.
First Page
015276
Recommended Citation
Fang JX, Villablanca PA, Frisoli TM, Giustino G, Lai LKL, Lee JC et al [Jabri A] Transjugular Approach for evoque transcatheter tricuspid valve replacement in patients with challenging anatomy. Circ Cardiovasc Interv. 2025 Aug 19:e015276. doi: 10.1161/CIRCINTERVENTIONS.125.015276. Epub ahead of print. PMID: 40827406.
DOI
10.1161/CIRCINTERVENTIONS.125.015276
ISSN
1941-7632
PubMed ID
40827406